class="img-responsive

Madrid, Spain
10 – 11 Feb 2026

class="img-responsive

Madrid, Spain
10 – 11 Feb 2026

AI 운영화: 입증된 AI 사용 사례를 생명과학 전반에서 일상적인 업무로 전환합니다.

class="img-responsive
Featured Speakers:
Felix Arellano

Global Head of Pharmacovigilance
Roche

class="img-responsive
class="img-responsive
Featured Speakers:
Julie Thomas

VP, Global Medical Safety Operations
Johnson & Johnson

class="img-responsive
class="img-responsive
Featured Speakers:
Andrea Rogers

Executive Director, R&D Informatics
Amgen

class="img-responsive

Letter From Our CEO: Nordic Capital Acquires ArisGlobal, Fuels Growth

It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Over these 32 years, ArisGlobal has built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed ArisGlobal to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.

Connected to the Future: Making Drug Safety Databases Transparent, E2B R3 Compliant and Cost-Effective

As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.